Search Results for: covid-19
Articles
DURECT Corporation Announces First Patient Dosed in Phase 2b AHFIRM Study January 28, 2021
DURECT Corporation recently announced it has dosed the first patient in its AHFIRM randomized, double-blind, placebo-controlled, multi-center Phase 2b study to evaluate the...Caladrius Biosciences Treats First Patient in the Phase 2b FREEDOM Trial January 21, 2021
Caladrius Biosciences, Inc. recently announced it has treated the first patient in its Phase 2b FREEDOM trial of CLBS16 as...SPECIAL FEATURE - Outsourcing Analytical Testing: Innovative Drugs Spike Demand for Advanced Analysis January 14, 2021
Contributor Cindy H. Dubin asked some of the key analytical testing providers to describe their offerings in several key areas and what advanced analytical testing techniques they can offer to pharma clients.
EXECUTIVE INTERVIEW - BiologIC Technologies: The Future Microsoft for the Biorevolution January 13, 2021
Richard Vellacott, CEO of BiologIC Technologies, discusses his company’s unique technology and its applications in the future of medicine and wider fields of synthetic biology.
EXECUTIVE INTERVIEW - Fortress Biotech, Inc.: Looking for the Muffin Tops January 13, 2021
Lindsay A. Rosenwald, MD, Chairman, President, and CEO of Fortress Biotech, discusses how his medical and financial knowledge come together to find successful drug candidates, the company’s partnership model, and the inefficiencies he sees in the biotech industry.
Catalyst Pharmaceuticals Announces Strategic Plan for Product Portfolio Expansion January 7, 2021
Catalyst Pharmaceuticals, Inc. recently announced an expansion in its strategic priorities related to portfolio planning and research and development. Catalyst...EyePoint Pharmaceuticals Announces $15.7-Million Equity Investment January 4, 2021
EyePoint Pharmaceuticals, Inc. recently announced Ocumension Therapeutics has made a $15.7-million equity investment in EyePoint. Under the terms of the...Syneos Health & ConcertAI Announce Strategic Collaboration to Accelerate the Use of Real World Evidence & AI to Advance Oncology Research December 9, 2020
Syneos Health and ConcertAI recently announced a strategic collaboration to accelerate and streamline the implementation of novel oncology clinical trial research and study designs…..
Biogen & Sage Therapeutics Announce Global Development & Commercialization Collaboration December 2, 2020
Biogen Inc. and Sage Therapeutics, Inc. recently announced they have executed a global collaboration and license agreement to jointly develop...Samsung Biologics Breaks Ground on Super Plant, the World’s Largest & Most Innovative Bio-Manufacturing Facility December 2, 2020
Samsung Biologics officially began construction of its Plant 4 in Incheon, South Korea. Dubbed the "Super Plant,” the new, multi-story...Gene Therapy Market to Surpass $6.21 Billion Globally, by 2027 at 13.4% CAGR December 2, 2020
Allied Market Research published a report, titled Gene Therapy Market by Vector Type (Viral Vector and Non-viral Vector), Gene Type...BioNTech & InstaDeep Announce Strategic Collaboration & Form AI Innovation Lab to Develop Novel Immunotherapies November 25, 2020
BioNTech SE and InstaDeep Ltd recently announced a multi-year strategic collaboration aimed at applying the latest advances in artificial intelligence (AI) and machine learning (ML) technology to develop….
Evaluation Kit for Sensirion’s Single-Use Liquid Flow Sensor LD20-2600B is Now Available for Distribution November 20, 2020
The LD20-2600B single-use liquid flow sensor for fast, precise and reliable measurements of the lowest flow rates in biomedical applications was successfully launched….
CalciMedica Announces Publication of Preclinical Data Demonstrating the Pathological Role of Microglial CRAC Channels in Ischemic Stroke November 18, 2020
CalciMedica Inc. recently announced the publication of preclinical data demonstrating a pathological role for CRAC channel-mediated microglial calcium activity in...4D Pharma Presents New Data From Two MRx0518 Clinical Trials November 11, 2020
4D pharma plc recently announced new positive clinical data from two clinical trials of MRx0518, its lead immuno-oncology single strain...Dolomite Microfluidics & MilliporeSigma Collaborate to Release Off-the-Shelf Microfluidic Device Kits for the Fabrication of PLGA Particles November 11, 2020
Dolomite Microfluidics and MilliporeSigma have partnered to create a range of off-the-shelf NanoFabTx™ microfluidic device kits for the production of….
Rubius Therapeutics Announces Dosing of First Patient with Relapsed/Refractory Acute Myeloid Leukemia in the Ongoing Phase 1/2 Clinical Trial November 5, 2020
Rubius Therapeutics, Inc. recently announced that the first patient with acute myeloid leukemia (AML) has been dosed in its ongoing...Cerevel Therapeutics Announces First Patients Dosed in all Phase 3 Trials for the Treatment of Parkinson’s Disease November 5, 2020
Cerevel Therapeutics recently announced that the first participants have been dosed in all three of the clinical trials in their...uniQure Announces Enrollment of Next Two Patients in Phase 1/2 Clinical Trial October 14, 2020
uniQure N.V. recently announced that two additional patient procedures have been completed in the Phase 1/2 clinical trial of AMT-130...WEBINAR SERIES ALERT - Learn About Complex Parenteral Drug Delivery From Evonik Industry Experts - Free Oct-Nov Webinar Series October 14, 2020
As a global CDMO leader for advanced drug delivery, Evonik invites you to join us for a webinar series on parenteral drug delivery. More than a dozen technical experts from Evonik will review….
